These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 23731764)
1. Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone. Gaugler B; Arbez J; Legouill S; Tiberghien P; Moreau P; Derenne S; Saas P; Mohty M Cytotherapy; 2013 Jul; 15(7):861-8. PubMed ID: 23731764 [TBL] [Abstract][Full Text] [Related]
2. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor. Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214 [TBL] [Abstract][Full Text] [Related]
3. Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease. Arbez J; Saas P; Lamarthée B; Malard F; Couturier M; Mohty M; Gaugler B Cytotherapy; 2015 Jul; 17(7):948-55. PubMed ID: 25813681 [TBL] [Abstract][Full Text] [Related]
4. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472 [TBL] [Abstract][Full Text] [Related]
5. Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF. Lundqvist A; Smith AL; Takahashi Y; Wong S; Bahceci E; Cook L; Ramos C; Tawab A; McCoy JP; Read EJ; Khuu HM; Bolan CD; Joo J; Geller N; Leitman SF; Calandra G; Dunbar C; Kurlander R; Childs RW J Immunol; 2013 Dec; 191(12):6241-9. PubMed ID: 24244025 [TBL] [Abstract][Full Text] [Related]
6. Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor. Varmavuo V; Mäntymaa P; Kuittinen T; Nousiainen T; Jantunen E Transfusion; 2012 Aug; 52(8):1785-91. PubMed ID: 22304442 [TBL] [Abstract][Full Text] [Related]
7. A Pilot, Exploratory, Randomized, Phase II Safety Study Evaluating Tumor Cell Mobilization and Apheresis Product Contamination in Patients Treated with Granulocyte Colony-Stimulating Factor Alone or Plus Plerixafor. Nahi H; Celanovic M; Liu Q; Lund J; Peceliunas V Biol Blood Marrow Transplant; 2019 Jan; 25(1):34-40. PubMed ID: 30149148 [TBL] [Abstract][Full Text] [Related]
8. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Tayebi H; Kuttler F; Saas P; Lienard A; Petracca B; Lapierre V; Ferrand C; Fest T; Cahn J; Blaise D; Kuentz M; Hervé P; Tiberghien P; Robinet E Exp Hematol; 2001 Apr; 29(4):458-70. PubMed ID: 11301186 [TBL] [Abstract][Full Text] [Related]
9. No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF. Gazitt Y; Akay C; Thomas C Stem Cells Dev; 2006 Apr; 15(2):269-77. PubMed ID: 16646673 [TBL] [Abstract][Full Text] [Related]
10. Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor-Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Comparative Study. Jaiswal SR; Bhakuni P; Joy A; Murli N; Bharadwaj P; Zaman S; Nedunchezian M; Chakrabarti S Biol Blood Marrow Transplant; 2018 Mar; 24(3):542-548. PubMed ID: 29191663 [TBL] [Abstract][Full Text] [Related]
11. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts. Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ J Transl Med; 2015 May; 13():145. PubMed ID: 25948100 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253 [TBL] [Abstract][Full Text] [Related]
13. Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation. Xuan L; Wu X; Qiu D; Gao L; Liu H; Fan Z; Huang F; Jin Z; Sun J; Li Y; Liu Q J Transl Med; 2018 May; 16(1):144. PubMed ID: 29801459 [TBL] [Abstract][Full Text] [Related]
14. Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol. Micallef IN; Stiff PJ; DiPersio JF; Maziarz RT; McCarty JM; Bridger G; Calandra G Biol Blood Marrow Transplant; 2009 Dec; 15(12):1578-86. PubMed ID: 19896082 [TBL] [Abstract][Full Text] [Related]
15. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial. Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613 [TBL] [Abstract][Full Text] [Related]
16. Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis. Spoerl S; Peter R; Wäscher D; Götze K; Verbeek M; Peschel C; Krackhardt AM Transfusion; 2017 Jan; 57(1):115-121. PubMed ID: 27859332 [TBL] [Abstract][Full Text] [Related]
17. [Effects of rhG-CSF mobilization on immunological properties of grafts from peripheral blood and bone marrow]. Zhao XY; Chang YJ; Huang XJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):787-90. PubMed ID: 16928322 [TBL] [Abstract][Full Text] [Related]
18. A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas. Hosing C; Munsell MF; Reuben JM; Popat U; Lee BN; Gao H; Körbling M; Shpall EJ; Kebriaei P; Alousi A; De Lima M; McMannis J; Qazilbash M; Anderlini P; Giralt S; Champlin RE; Khouri I J Blood Med; 2010; 1():49-55. PubMed ID: 22282683 [TBL] [Abstract][Full Text] [Related]
19. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor. Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358 [TBL] [Abstract][Full Text] [Related]
20. Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide. Shaughnessy P; Islas-Ohlmayer M; Murphy J; Hougham M; MacPherson J; Winkler K; Silva M; Steinberg M; Matous J; Selvey S; Maris M; McSweeney PA Biol Blood Marrow Transplant; 2011 May; 17(5):729-36. PubMed ID: 20813198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]